Institutional members access full text with Ovid®

Share this article on:

Pelvic Reconstruction with a Structural Pelvic Allograft After Resection of a Malignant Bone Tumor

Delloye, Christian MD, PhD; Banse, Xavier MD, PhD; Brichard, Bénédicte MD, PhD; Docquier, Pierre-Louis MD; Cornu, Olivier MD

Journal of Bone & Joint Surgery - American Volume: March 2007 - Volume 89 - Issue 3 - p 579–587
doi: 10.2106/JBJS.E.00943
Scientific Articles
Supplementary Content

Background: Reconstruction of the pelvic arch after resection of a malignant pelvic tumor remains a major surgical challenge because of the high rate of associated complications. The purpose of this investigation was to assess the functional outcome and complication rate following treatment with a bone allograft to reconstruct the pelvis.

Methods: Twenty-four consecutive patients underwent excision of a malignant pelvic bone tumor and reconstruction with a pelvic bone allograft. The living patients were followed for a minimum of twenty-four months. There were nineteen primary malignant bone tumors, sixteen of which were high-grade sarcomas, and there were five isolated metastases. Patients were examined clinically and radiographically and were assessed functionally with the Musculoskeletal Tumor Society score.

Results: The mean age of the patients at the time of the index surgery was thirty-four years, and the mean duration of follow-up was forty-one months. Eighteen of the twenty-four resections involved the periacetabular area and were followed by reconstruction either with a hip prosthesis (thirteen) or with an osteochondral allograft alone (five). The six other resections involved the iliac bone. All patients received a massive bone allograft that had been sterilely procured without secondary irradiation. At the time of our last evaluation, eight patients were alive and free of disease. Seven patients had a local recurrence. Neurological deficits were present in six patients, and three had a deep infection. Nonunion of three of the sixteen allografts that could be evaluated was observed. Neither graft fracture nor lysis was observed. Eleven patients underwent surgical revision, with nine of these revisions related to the reconstruction. The average Musculoskeletal Tumor Society score at the time of the latest follow-up was 73% of the maximal possible score. The average score was 82% for the eleven patients with an age of less than twenty years at the time of the index procedure and 65% for the thirteen older patients. Ten patients walked without any assistive device, and five of them had normal function with no or only a slight limp.

Conclusions: Pelvic reconstruction after a limb-sparing resection is associated with a high risk of surgical complications and usually should be reserved for patients with a primary bone sarcoma. A pelvic allograft can restore the anatomy and provide good functional results, especially in young patients. Nonunion was the most common allograft-related complication.

Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.

1 Divisions of Orthopaedic Surgery (C.D., X.B., P.-L.D., and O.C.) and Pediatric Oncology (B.B.), Department of Surgery, Cliniques Universitaires St.-Luc, 10, avenue Hippocrate, B1200 Brussels, Belgium. E-mail address for C. Delloye: delloye@orto.ucl.ac.be

Copyright 2007 by The Journal of Bone and Joint Surgery, Incorporated
You currently do not have access to this article

To access this article: